The effect of groin treatment modality and sequence on clinically significant chronic lymphedema in patients with vulvar carcinoma

Jessica Berger; Eirwen Scott; Paniti Sukumvanich; Ashlee Smith; Alexander Olawaiye; John Comerci; Joseph L. Kelley; Sushil Beriwal; Marilyn Huang

doi:10.1097/IGC.0000000000000311

The effect of groin treatment modality and sequence on clinically significant chronic lymphedema in patients with vulvar carcinoma

Jessica Berger, Eirwen Scott, Paniti Sukumvanich, Ashlee Smith, Alexander Olawaiye, John Comerci, Joseph L. Kelley, Sushil Beriwal, Marilyn Huang

Obstetrics & Gynecology and Women's Health

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Abstract

Objective: Chronic lymphedema (CL) after inguinal lymph node dissection (ILND) or radiotherapy (RT) is a significant problem for vulvar cancer survivors. The treatment modality or combination of therapies that poses the greatest risk is not known. The objective of this study was to describe rates of clinically significant CL conferred by different groin treatment modalities.

Original language	English (US)
Pages (from-to)	119-124
Number of pages	6
Journal	International Journal of Gynecological Cancer
Volume	25
Issue number	1
DOIs	https://doi.org/10.1097/IGC.0000000000000311
State	Published - Jan 1 2015

Keywords

Lymphadenectomy
Lymphedema
Radiotherapy
Vulvar carcinoma

ASJC Scopus subject areas

Oncology
Obstetrics and Gynecology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1097/IGC.0000000000000311

Cite this

@article{0308a8b8aa8643a88d5c1263cb78c82d,

title = "The effect of groin treatment modality and sequence on clinically significant chronic lymphedema in patients with vulvar carcinoma",

abstract = "Objective: Chronic lymphedema (CL) after inguinal lymph node dissection (ILND) or radiotherapy (RT) is a significant problem for vulvar cancer survivors. The treatment modality or combination of therapies that poses the greatest risk is not known. The objective of this study was to describe rates of clinically significant CL conferred by different groin treatment modalities.",

keywords = "Lymphadenectomy, Lymphedema, Radiotherapy, Vulvar carcinoma",

author = "Jessica Berger and Eirwen Scott and Paniti Sukumvanich and Ashlee Smith and Alexander Olawaiye and John Comerci and Kelley, {Joseph L.} and Sushil Beriwal and Marilyn Huang",

year = "2015",

month = jan,

day = "1",

doi = "10.1097/IGC.0000000000000311",

language = "English (US)",

volume = "25",

pages = "119--124",

journal = "International Journal of Gynecological Cancer",

issn = "1048-891X",

publisher = "Lippincott Williams and Wilkins",

number = "1",

}

TY - JOUR

T1 - The effect of groin treatment modality and sequence on clinically significant chronic lymphedema in patients with vulvar carcinoma

AU - Berger, Jessica

AU - Scott, Eirwen

AU - Sukumvanich, Paniti

AU - Smith, Ashlee

AU - Olawaiye, Alexander

AU - Comerci, John

AU - Kelley, Joseph L.

AU - Beriwal, Sushil

AU - Huang, Marilyn

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Objective: Chronic lymphedema (CL) after inguinal lymph node dissection (ILND) or radiotherapy (RT) is a significant problem for vulvar cancer survivors. The treatment modality or combination of therapies that poses the greatest risk is not known. The objective of this study was to describe rates of clinically significant CL conferred by different groin treatment modalities.

AB - Objective: Chronic lymphedema (CL) after inguinal lymph node dissection (ILND) or radiotherapy (RT) is a significant problem for vulvar cancer survivors. The treatment modality or combination of therapies that poses the greatest risk is not known. The objective of this study was to describe rates of clinically significant CL conferred by different groin treatment modalities.

KW - Lymphadenectomy

KW - Lymphedema

KW - Radiotherapy

KW - Vulvar carcinoma

UR - http://www.scopus.com/inward/record.url?scp=84928011194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928011194&partnerID=8YFLogxK

U2 - 10.1097/IGC.0000000000000311

DO - 10.1097/IGC.0000000000000311

M3 - Article

C2 - 25415076

AN - SCOPUS:84928011194

SN - 1048-891X

VL - 25

SP - 119

EP - 124

JO - International Journal of Gynecological Cancer

JF - International Journal of Gynecological Cancer

IS - 1

ER -

The effect of groin treatment modality and sequence on clinically significant chronic lymphedema in patients with vulvar carcinoma

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this